ubiquitin specific protease-7 inhibitors (Medivir)

N/A

Report date: 2025/03/20 09:46:12
NME

Base Information

Drug Nameubiquitin specific protease-7 inhibitors (Medivir)
Drug Alias NameUSP7 inhibitors (Medivir)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 7 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 7
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesUbiquigent Ltd
Inactive CompaniesMedivir AB
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A